The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARDELYX INC | CALL | 039697907 | 4,624,816 | 1,179,800 | SH | Call | SOLE | 1,179,800 | 0 | 0 | |
| ARDELYX INC | COM | 039697107 | 5,608,454 | 1,430,728 | SH | SOLE | 1,430,728 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 302,923 | 2,412 | SH | SOLE | 2,412 | 0 | 0 | ||
| BIOHAVEN LTD | CALL | G1110E907 | 2,822,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| BIOHAVEN LTD | COM | G1110E107 | 9,498,372 | 673,166 | SH | SOLE | 673,166 | 0 | 0 | ||
| CAVA GROUP INC | COM | 148929102 | 1,566,678 | 18,600 | SH | SOLE | 18,600 | 0 | 0 | ||
| FORIAN INC | COM | 34630N106 | 2,677,570 | 1,366,107 | SH | SOLE | 1,366,107 | 0 | 0 | ||
| GENEDX HOLDINGS CORP | CALL | 81663L900 | 9,231,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| GENEDX HOLDINGS CORP | COM CL A | 81663L200 | 85,151,729 | 922,454 | SH | SOLE | 922,454 | 0 | 0 | ||
| PALANTIR TECHNOLOGIES INC | CL A | 69608A108 | 4,021,440 | 29,500 | SH | SOLE | 29,500 | 0 | 0 | ||
| QUIDELORTHO CORP | COM | 219798105 | 3,409,147 | 118,291 | SH | SOLE | 118,291 | 0 | 0 | ||
| SPRINGWORKS THERAPEUTICS INC | CALL | 85205L907 | 7,048,500 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| TELADOC HEALTH INC | CALL | 87918A905 | 6,533,371 | 750,100 | SH | Call | SOLE | 750,100 | 0 | 0 | |
| TELADOC HEALTH INC | COM | 87918A105 | 3,318,510 | 381,000 | SH | SOLE | 381,000 | 0 | 0 | ||